SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-12-013318
Filing Date
2012-03-06
Accepted
2012-03-06 17:25:32
Documents
3
Period of Report
2012-02-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v304930_8k.htm 8-K 20601
2 EXHIBIT 10.1 v304930_ex10-1.htm EX-10.1 21277
3 EXHIBIT 10.2 v304930_ex10-2.htm EX-10.2 29949
  Complete submission text file 0001144204-12-013318.txt   73185
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 12671573
SIC: 4731 Arrangement of Transportation of Freight & Cargo